
Why ASCO Is a Must-Attend Event for Oncologists Worldwide
Leaders in oncology share why the American Society of Clinical Oncology (ASCO) meeting remains a top global gathering for breakthroughs, networking, and lifelong learning.
Oncology professionals reflect on the unique value of attending the
Here is what the following attendees who spoke with The American Journal of Managed Care® had to say about the event:
- Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre
- Vincent Picozzi, MD, medical oncologist and director of the Pancreaticobiliary Program, Virginia Mason
- Danny Rischin, MD, medical oncologist, clinician researcher, Peter McCallum Cancer Centre in Melbourne, Australia
This transcript was lightly edited; captions were auto-generated.
Transcript
What is your favorite thing about attending ASCO?
Arnold: It’s always about learning, and learning is so great, so that’s a great week of oncology. We can learn so much about new trials, new results which come out, and also new strategies for our patients. And of course, it’s also networking. It’s meeting with colleagues and friends. So therefore, it’s always a great week—in this year and every year. And yeah, hopefully we’ll all have a great and joyful and super exciting ASCO.
Picozzi: Well, I like Italian food, so Chicago is always good for that. But really, the thing I like about ASCO is getting to see my colleagues and peers from around the country and around the world. It’s probably the best place to engage other thought leaders, and so I really look forward to seeing my colleagues worldwide every year.
Rischin: I’ve been coming to ASCO regularly over the last 25 years or so. I think the key thing is that at the meeting, major findings of new studies—studies that change clinical practice—are presented. It’s an opportunity to interact with your colleagues and discuss new findings. It’s a stimulating opportunity to interact and learn more about new treatments.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.